Acetamide,N-1,3-benzodioxol-5-yl-

Suppliers

Names

[ Name ]:
Acetamide,N-1,3-benzodioxol-5-yl-

[Synonym ]:
5-acetamido-1,3-benzodioxole
Acetamide,N-1,3-benzodioxol-5-yl
5-acetamino-1,3-benzodioxole
N-1,3-Benzodioxol-5-ylacetamide

Chemical & Physical Properties

[ Density]:
1.34g/cm3

[ Boiling Point ]:
367.4ºC at 760mmHg

[ Molecular Formula ]:
C₉H₉NO₃

[ Molecular Weight ]:
179.17300

[ Flash Point ]:
176ºC

[ Exact Mass ]:
179.05800

[ PSA ]:
47.56000

[ LogP ]:
1.44670

[ Vapour Pressure ]:
1.37E-05mmHg at 25°C

[ Index of Refraction ]:
1.615

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: AB4542510

CHEMICAL NAME :: Acetamide, N-1,3-benzodioxol-5-yl-

CAS REGISTRY NUMBER :: 13067-19-1

LAST UPDATED :: 199606

DATA ITEMS CITED :: 4

MOLECULAR FORMULA :: C9-H9-N-O3

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 1 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0052887

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 410 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0052887

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 660 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0052887

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 250 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0052887

Safety Information

[ HS Code ]:
2932999099

Synthetic Route

Click to get detail synthetic route

Customs

[ HS Code ]: 2932999099

[ Summary ]:
2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Related Compounds

4H-1,4-Benzoxazine-4-acetamide,N-1,3-benzodioxol-5-yl-2-ethyl-2,3-dihydro-3-oxo-(9CI)
4H-1,4-Benzoxazine-4-acetamide,N-1,3-benzodioxol-5-yl-2-ethyl-2,3-dihydro-6-methyl-3-oxo-(9CI)
N-(1,3-Benzodioxol-5-yl)-2-{[4-(4-bromophenyl)-5-(3-pyridinyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide
Acetamide, N-1,3-benzodioxol-5-yl-2-[(1,4-dihydro-5,6-dimethyl-4-oxothieno[2,3-d]pyrimidin-2-yl)thio]- (9CI)
WAY-657568
LX-2343
N-[(1,3-dimethylpyrazol-4-yl)methyl]-1-ethyl-5-methylpyrazol-4-amine;hydrochloride
N-[(1,4-dimethyl-1H-pyrazol-5-yl)methyl]-1-isopropyl-3-methyl-1H-pyrazol-4-amine
3-[[(1-Ethylpyrazol-4-yl)amino]methyl]phenol;hydrochloride
N-[(1-ethyl-5-fluoro-3-methylpyrazol-4-yl)methyl]-1-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]methanamine;hydrochloride
2-(4-Acetylphenyl)-1,3-thiazole-5-carboxylic acid
7-Bromo-5-nitro-1H-indole-2-carboxylic acid
3-Cyclohexyl-6-methyl-1,2-dihydropyrazin-2-one
2-(2-Bromo-6-fluorophenyl)benzaldehyde
[(2R,3S,4S,5R,6S)-6-[(2S,3R,4S,5S,6R)-4,5-Dihydroxy-2-[5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-3-yl]oxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
4-methyl-2-(pyridin-2-yl)-1H-imidazole-5-carboxylic acid dihydrochloride

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.